Magnetic Resonance Imaging

Medicine & Life Sciences

1. Renal Cell Carcinoma 100%
2. Magnetic Resonance Imaging 92%
3. Kidney 61%
4. Radiology 56%
5. Multiparametric Magnetic Resonance Imaging 51%
6. Neoplasms 45%
7. Fats 42%
8. Magnetic Resonance Spectroscopy 40%
9. Prostate 37%
10. Pelvic Floor 35%
11. Liver 32%
12. Prostatic Neoplasms 30%
13. Radiologists 27%
14. Biopsy 26%
15. Kidney Neoplasms 22%
16. Pelvic Floor Disorders 20%
17. Hepatocellular Carcinoma 20%
18. Defecography 16%
19. Pancreatic Cyst 13%
20. Radiosurgery 13%
21. Therapeutics 13%
22. Tomography 13%
23. Protons 12%
24. Perfusion 12%
25. Abdomen 12%
26. Gadolinium 12%
27. Guidelines 12%
28. Data Systems 11%
29. Fibrosis 11%
30. Contrast Media 11%
31. Histology 10%
32. Non-alcoholic Fatty Liver Disease 10%
33. Pelvis 10%
34. Cysts 10%
35. Neoplasm Metastasis 10%
36. Watchful Waiting 10%
37. Research Ethics Committees 10%
38. Prostatectomy 10%
39. Deep Learning 10%
40. Thrombosis 9%
41. Iron 9%
42. Health Insurance Portability and Accountability Act 8%
43. Perfusion Imaging 8%
44. Artifacts 8%
45. Radiotherapy 8%
46. Growth 7%
47. Ultrasonography 7%
48. Surgeons 7%
49. Stress Urinary Incontinence 7%
50. Biomarkers 7%
51. Cystocele 7%
52. Rectal Neoplasms 7%
53. Pathology 7%
54. Response Evaluation Criteria in Solid Tumors 6%
55. Colon 6%
56. Inferior Vena Cava 6%
57. Thorax 6%
58. Pancreas 6%
59. cabozantinib 6%
60. Respiration 6%
61. Prolapse 6%
62. Appendicitis 6%
63. Suburethral Slings 6%
64. Adenocarcinoma 6%
65. Liver Cirrhosis 6%
66. Signal-To-Noise Ratio 6%
67. Pregnancy 5%
68. Pelvic Organ Prolapse 5%
69. Necrosis 5%
70. Fatty Liver 5%
71. Angiomyolipoma 5%
72. Expert Testimony 5%
73. Sensitivity and Specificity 5%
74. Prostatic Hyperplasia 5%
75. Neoplasm Staging 5%
76. Water 5%
77. Confidence Intervals 5%
78. Survival 5%
79. Noise 5%
80. Incidental Findings 5%
81. Prostate-Specific Antigen 5%
82. Mutation 5%
83. Abdominal Pain 5%
84. Anatomy 5%
85. PT2399 5%